Study to Identify and Measure the Values and Palliative Care Pref. of Hindu Patients and Their Caregivers

NCT05538481 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-07-07

No results posted yet for this study

Summary

Historically, palliative care in the US has been rooted in the cultural values of a Caucasian, Christian middle class. Greater understanding of how culture influences the delivery of palliative care to minority patients is needed to achieve health equity.

The purpose of this study is to learn more about the cultural values (Hindu customs and beliefs) and palliative care (specialized care for people living with a serious illness) preferences of the Hindu community. To the study team's knowledge, there has not been another study that has used a research approach to help better understand and measure the cultural values and palliative care preferences of Hindu participants with cancer and their caregivers.

Conditions

  • Neoplasms

Interventions

OTHER

Semi-structured interview

A collection of individual cultural values and palliative care preferences within the focus group meetings

OTHER

Developed survey completion

A collection of individual responses to a survey created after focus group completion and analysis

OTHER

Systems of Belief Inventory (SBI-15R)

A 15-item questionnaire designed to measure religious and spiritual beliefs and practices and the social support derived from a community sharing those beliefs.

Sponsors & Collaborators

  • Atrium Health Levine Cancer Institute

    collaborator OTHER
  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Rushil Patel, MD · Atrium Health Levine Cancer Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-30
Primary Completion
2023-12-31
Completion
2024-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05538481 on ClinicalTrials.gov